| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/13/2001 | US6200293 Fluid delivery device with temperature controlled energy source |
| 03/13/2001 | US6199607 Formulation for inhalation |
| 03/13/2001 | US6199554 Method and apparatus for combining injury-mediated therapy and drug delivery |
| 03/13/2001 | CA2170647C Multiple unit tableted dosage form i |
| 03/13/2001 | CA2135132C Lysine derivatives with an n6-alkoxy or alkenoxycarbonyl group, their preparation and use in cosmetic, pharmaceutical, hygyenic or dietetic compositions |
| 03/13/2001 | CA2010934C Sustained release bolus effective for the prolonged prevention, treatment or control of nematode, acarid and endo- and ectoparasitic infestations of ruminants |
| 03/11/2001 | CA2486805A1 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate |
| 03/08/2001 | WO2001016575A1 Glucose biosensor |
| 03/08/2001 | WO2001016220A1 Method of producing an absorbent foam material |
| 03/08/2001 | WO2001016218A1 Rapidly decomposing chitosan-based pellets |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001016106A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 03/08/2001 | WO2001016093A1 SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 03/08/2001 | WO2001015889A1 Method and device for producing tablets |
| 03/08/2001 | WO2001015799A1 Method for encapsulating active substances by coacervation of polymers in non-chlorinated organic solvent |
| 03/08/2001 | WO2001015777A1 Pulmonary-administration of mineral ascorbates |
| 03/08/2001 | WO2001015755A2 Methods and compositions for delivery of pharmaceutical agents |
| 03/08/2001 | WO2001015750A1 Hydrogel wound dressing containing liposome-encapsulated therapeutic agent |
| 03/08/2001 | WO2001015745A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | WO2001015735A1 Matrix adhering to nasal mucosa |
| 03/08/2001 | WO2001015734A2 High viscosity liquid controlled delivery system and medical or surgical device |
| 03/08/2001 | WO2001015726A2 Compositions for stimulating cytokine secretion and inducing an immune response |
| 03/08/2001 | WO2001015724A1 Improved stable formulations of ace inhibitors, and methods for preparation thereof |
| 03/08/2001 | WO2001015718A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof |
| 03/08/2001 | WO2001015713A1 Maca and antler for augmenting testosterone levels |
| 03/08/2001 | WO2001015702A1 Soft capsules |
| 03/08/2001 | WO2001015701A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 03/08/2001 | WO2001015700A1 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 03/08/2001 | WO2001015699A1 Injectable buprenorphine microparticle compositions and their use |
| 03/08/2001 | WO2001015691A1 Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 03/08/2001 | WO2001015688A1 Ibuprofen-containing softgels |
| 03/08/2001 | WO2001015683A1 Delayed-action form of administration containing tramadol saccharinate |
| 03/08/2001 | WO2001015682A1 Pharmaceutical tramadol salts |
| 03/08/2001 | WO2001015681A1 Oral pharmaceutical forms of administration with a delayed action |
| 03/08/2001 | WO2001015677A2 Use of 5-ht1b/1d agonists to treat otic pain |
| 03/08/2001 | WO2001015675A2 Use of docetaxel for treating hepatocellular carcinoma |
| 03/08/2001 | WO2001015671A2 Flushable disposable polymeric products |
| 03/08/2001 | WO2001015670A1 Treatment of fungal infections utilizing a fungal growth medium |
| 03/08/2001 | WO2001015669A1 Pharmaceutical preparation containing nanosol |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015667A1 Oral dosage forms |
| 03/08/2001 | WO2001015666A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 03/08/2001 | WO2001015665A1 Controlled release oral dosage suitable for oral administration |
| 03/08/2001 | WO2001015664A2 Coformulation methods and their products |
| 03/08/2001 | WO2001015657A1 Denture adhesive compositions |
| 03/08/2001 | WO2001015643A1 Absorbent foam material and an absorbent structure containing said foam material |
| 03/08/2001 | WO2001015554A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | WO2001015553A1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 03/08/2001 | WO2001015547A2 Active agent preparation for veterinary use and method for the production thereof |
| 03/08/2001 | WO2000064416A3 Pharmaceutical formulation of tamoxifen citrate |
| 03/08/2001 | WO2000061766A3 Telomerase-specific cancer vaccine |
| 03/08/2001 | WO2000057870A3 Viral treatment |
| 03/08/2001 | WO2000054762A3 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 03/08/2001 | WO2000041546A9 Novel exendin agonist formulations and methods of administration thereof |
| 03/08/2001 | WO2000039290A3 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 03/08/2001 | WO2000006243A3 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 03/08/2001 | DE19942417A1 Orally administered composition for obtaining satiation effect and/or improving gastric function, containing crosslinked uronic acid-containing polysaccharide in sponge form |
| 03/08/2001 | DE19941997A1 Verfahren und Vorrichtung zur Herstellung einer Tablette o. dgl. Method and apparatus for producing a tablet o. The like. |
| 03/08/2001 | DE19940227A1 Phospholipidgel Phospholipid |
| 03/08/2001 | CA2403271A1 Maca and antler for augmenting testosterone levels |
| 03/08/2001 | CA2391844A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | CA2388560A1 Sustained-release form of administration containing tramadol saccharinate |
| 03/08/2001 | CA2383002A1 Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof |
| 03/08/2001 | CA2382611A1 Compositions for stimulating cytokine secretion and inducing an immune response |
| 03/08/2001 | CA2382556A1 Coformulation methods and their products |
| 03/08/2001 | CA2382449A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | CA2381813A1 Treatment of fungal infections utilizing a fungal growth medium |
| 03/08/2001 | CA2380867A1 Absorbent foam material and an absorbent structure containing said foam material |
| 03/08/2001 | CA2345779A1 Hydrogel wound dressing containing liposome-encapsulated therapeutic agent |
| 03/07/2001 | EP1080733A1 Solid preparations for oral administration of drugs relating to genes |
| 03/07/2001 | EP1080731A2 Composition and device structure for iontophoresis |
| 03/07/2001 | EP1080721A2 Non-crystalline solid dispersant comprising cefuromixe axetil |
| 03/07/2001 | EP1080720A1 Fat emulsions for inhalational administration |
| 03/07/2001 | EP1080719A2 Methods for potentiation of efficacy of topical actives by mono-acyl-(lyso)-glycerophosholipids |
| 03/07/2001 | EP1080718A1 Composition for sustained release of human growth hormone |
| 03/07/2001 | EP1080717A1 Method for dispensing antioxidant vitamins by inhalation |
| 03/07/2001 | EP1080226A1 Compositions and methods for topical delivery of oligonucleotides |
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 03/07/2001 | EP1080103A1 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 03/07/2001 | EP1080100A1 Cytosine deaminase gene |
| 03/07/2001 | EP1080060A2 Crystallization of xylitol, crystalline xylitol product and use thereof |
| 03/07/2001 | EP1079918A1 Microencapsulation and electrostatic processing method |
| 03/07/2001 | EP1079857A1 Combination meningitidis b/c vaccines |
| 03/07/2001 | EP1079850A1 Compound delivery using rapidly dissolving collagen film |
| 03/07/2001 | EP1079839A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
| 03/07/2001 | EP1079834A1 Stabile compositions comprising levosimendan and alginic acid |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | EP1079823A1 Compositions comprising organic mono- or dinitrate for treating impotence |
| 03/07/2001 | EP1079822A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate |
| 03/07/2001 | EP1079815A1 Timed-release transdermal systems containing an active ingredient |
| 03/07/2001 | EP1079814A1 Layering process and apparatus therefor |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079812A1 Novel particulate formulations |
| 03/07/2001 | EP1079811A1 Biodegradable sustained-release alginate gels |
| 03/07/2001 | EP1079810A1 Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract |
| 03/07/2001 | EP1079809A1 Enteric coated pharmaceutical composition and method of manufacturing |
| 03/07/2001 | EP1079808A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/07/2001 | EP1079807A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| 03/07/2001 | EP1079806A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |